Targeting the JNK signaling pathway potentiates the antiproliferative efficacy of rapamycin in LS174T colon cancer cells

Journal of Surgical Research

Volumn 167, Issue 2, 2011, Pages

  Benoit, Michael ^a   Dormond Meuwly, Anne ^a   Demartines, Nicolas ^a   Dormond, Olivier ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

JNK; mTOR; proliferation; rapamycin; signaling; tumor

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLON CANCER; DRUG EFFICACY; DRUG POTENTIATION; DRUG TARGETING; ENZYME PHOSPHORYLATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; ANTHRACENES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; ENZYME INHIBITORS; FEMALE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, NUDE; MODELS, ANIMAL; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SIROLIMUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79954618950     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.01.015     Document Type: Article

References (32)

1. S. Wullschleger, R. Loewith, and M.N. Hall TOR signaling in growth and metabolism Cell 124 2006 471
2. D.A. Guertin, and D.M. Sabatini Defining the role of mTOR in cancer Cancer Cell 12 2007 9
3. D.D. Sarbassov, S.M. Ali, and S. Sengupta Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol Cell 22 2006 159
4. J.B. Easton, and P.J. Houghton mTOR and cancer therapy Oncogene 25 2006 6436
5. S. Faivre, G. Kroemer, and E. Raymond Current development of mTOR inhibitors as anticancer agents Nat Rev Drug Discov 5 2006 671
6. A. Efeyan, and D.M. Sabatini mTOR and cancer: Many loops in one pathway Curr Opin Cell Biol 22 2010 169
7. R.J. Davis Signal transduction by the JNK group of MAP kinases Cell 103 2000 239
8. C.R. Weston, and R.J. Davis The JNK signal transduction pathway Curr Opin Cell Biol 19 2007 142
9. L. Chang, and M. Karin Mammalian MAP kinase signalling cascades Nature 410 2001 37
10. D.N. Dhanasekaran, and E.P. Reddy JNK signaling in apoptosis Oncogene 27 2008 6245
11. E.F. Wagner, and A.R. Nebreda Signal integration by JNK and p38 MAPK pathways in cancer development Nat Rev Cancer 9 2009 537
12. P. Vivas-Mejia, J.M. Benito, and A. Fernandez c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer Clin Cancer Res 16 2010 184
13. T. Miyazaki, J.D. Bub, and Y. Iwamoto c-Jun NH(2)-terminal kinase mediates leptin-stimulated androgen-independent prostate cancer cell proliferation via signal transducer and activator of transcription 3 and Akt Biochim Biophys Acta 1782 2008 593
14. H. Endo, K. Hosono, and T. Fujisawa Involvement of JNK pathway in the promotion of the early stage of colorectal carcinogenesis under high-fat dietary conditions Gut 58 2009 1637
15. A. Klippel, C. Reinhard, and W.M. Kavanaugh Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways Mol Cell Biol 16 1996 4117
16. I. Vivanco, N. Palaskas, and C. Tran Identification of the JNK signaling pathway as a functional target of the tumor suppressor PTEN Cancer Cell 11 2007 555
17. B. Derijard, M. Hibi, and I.H. Wu JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell 76 1994 1025
18. C.L. Sawyers Cancer: Mixing cocktails Nature 449 2007 993
19. Z.A. Knight, H. Lin, and K.M. Shokat Targeting the cancer kinome through polypharmacology Nat Rev Cancer 10 2010 130
20. E. Abdelnour-Berchtold, Y. Cerantola, and D. Roulin Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin Anticancer Res 30 2010 799
21. Y.J. Zhang, S.L. Zhao, and X.Q. Tian Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer Int J Colorectal Dis 24 2009 629
22. A. Carracedo, L. Ma, and J. Teruya-Feldstein Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer J Clin Invest 118 2008 3065
23. E. Buck, A. Eyzaguirre, and E. Brown Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors Mol Cancer Ther 5 2006 2676
24. Y. Rong, V.E. Belozerov, and C. Tucker-Burden Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity Cancer Res 69 2009 2540
25. Y. Kawasaki, S. Harashima, and M. Sasaki Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation Horm Metab Res 42 2010 311
26. S. Huang, L. Shu, and M.B. Dilling Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1) Mol Cell 11 2003 1491
27. S. Huang, L. Shu, and J. Easton Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity J Biol Chem 279 2004 36490
28. A.S. Nateri, B. Spencer-Dene, and A. Behrens Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development Nature 437 2005 281
29. H. Wang, M. Birkenbach, and J. Hart Expression of Jun family members in human colorectal adenocarcinoma Carcinogenesis 21 2000 1313
30. P. Gulhati, Q. Cai, and J. Li Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer Clin Cancer Res 15 2009 7207
31. D. Roulin, Y. Cerantola, and A. Dormond-Meuwly Targeting mTORC2 inhibits colon cancer cell proliferation in vitro and tumor formation in vivo Mol Cancer 9 2010 57
32. Y.J. Zhang, Q. Dai, and D.F. Sun mTOR signaling pathway is a target for the treatment of colorectal cancer Ann Surg Oncol 16 2009 2617